Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2012

Xtandi(Enzalutamide)Astellas Pharma Inc. logo4503.T

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Astellas Pharma Inc.

$3.40B

Medicare cost, 2024

Medicare drug plans spent $3.4 billion on Xtandi (enzalutamide) in 2024, for 255,605 prescriptions and refills filled by 35,359 patients. It ranks 14th among all drugs by Medicare drug plan spending. Spending rose 31% from 2023 to 2024. At about $13,301 per prescription it is a high-cost drug.

Medicare cost, 2024

$3.40B

+30.8% from 2023

Prescriptions

256K

$13,301.42 per claim

Patients

35K

12,459 prescribers

Total spending, 2024

$3.40B

$96,156.56 per patient

Questions and answers

How much does Medicare spend on Xtandi?

Medicare prescription drug plans paid $3.40B for Xtandi in 2024, for 255,605 prescriptions and refills to 35,359 patients (up 30.8% from 2023). The average cost per claim was $13,301.42.

Which state spends the most on Xtandi?

California had the highest Medicare cost for Xtandi in 2024: $353.8M for 27,174 claims, followed by Florida ($278.2M).

Who prescribes Xtandi the most?

Sukumar Ethirajan, hematology in Overland Park, KS, had the highest Medicare cost for Xtandi in 2024: 1,540 claims costing $21.5M.

Who makes Xtandi?

Xtandi is made by Astellas Pharma Inc. (4503.T), listed in the Medicare spending data as Astellas Pharma.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Xtandi was $3.40B in 2024, the highest year shown.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Xtandi, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Sukumar Ethirajan Overland Park, KSHematology1,540229$21.5M
Ryan J Malone Jeffersonville, INUrology777107$10.5M
Geoffrey J Bisignani Latrobe, PAUrology66971$8.9M
John M Rutkowski Sanborn, NYUrology63386$8.0M
Luke T Nordquist Omaha, NEMedical Oncology54082$7.3M
Stewart T Landau American Fork, UTUrology48672$6.7M
Zachary D Reardon Mobile, ALUrology50663$6.7M
Peter A Zeman Wilmington, NCUrology48257$6.5M
Aaron D Berger Chicago Ridge, ILUrology48176$6.4M
Timothy J Leroy Knoxville, TNUrology42758$6.0M
Benjamin H Lowentritt Baltimore, MDUrology37970$5.5M
Walter Rayford Memphis, TNUrology39272$5.4M
William B Townsend Charlotte, NCUrology37649$5.2M
Jim Hsiang Corpus Christi, TXRadiation Oncology35245$4.9M
Mark D Greenberger Memphis, TNUrology35848$4.9M
Daniel C Danila New York, NYMedical Oncology34857$4.8M
Brian R Evans Florence, SCUrology34445$4.7M
Mark J Saslawsky Memphis, TNUrology34034$4.6M
Mark G Delworth Jr. Blue Ash, OHUrology34236$4.5M
Susan M Sargent Rochester, NYNurse Practitioner36450$4.5M
Joelle P Hamilton Homewood, ALMedical Oncology33857$4.4M
David S Morris Hendersonville, TNUrology32259$4.3M
Pratik S Desai Woodbridge, VAUrology29439$4.1M
Scott B Sellinger Tallahassee, FLUrology28431$3.9M
David Degrassi Huntley, ILNurse Practitioner32357$3.6M

Prescriber data by year

YearPrescribersClaimsPatientsCost
202210,877189,07927,801$2.44B
202311,194191,56528,632$2.60B
202412,459255,60535,359$3.40B

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Astellas Pharma4503.T logo4503.T255,669$3.40B

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
5
RxNorm concept IDs
1307303, 1307309, 2390644, 2390646, 2390648
Application numbers
NDA203415, NDA213674

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube